• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

THE EFFECT IN PATIENTS OF STREPTOCOCCAL FIBRINOLYSIN (STREPTOKINASE) AND STREPTOCOCCAL DESOXYRIBONUCLEASE ON FIBRINOUS, PURULENT, AND SANGUINOUS PLEURAL EXUDATIONS.

作者信息

Tillett W S, Sherry S

机构信息

Department of Medicine, New York University College of Medicine, New York City.

出版信息

J Clin Invest. 1949 Jan;28(1):173-90. doi: 10.1172/JCI102046.

DOI:10.1172/JCI102046
PMID:16695653
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC439589/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1a/439589/5ab3ed2d012d/jcinvest00394-0198-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1a/439589/b56650e8cc2b/jcinvest00394-0196-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1a/439589/5ab3ed2d012d/jcinvest00394-0198-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1a/439589/b56650e8cc2b/jcinvest00394-0196-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1a/439589/5ab3ed2d012d/jcinvest00394-0198-a.jpg

相似文献

1
THE EFFECT IN PATIENTS OF STREPTOCOCCAL FIBRINOLYSIN (STREPTOKINASE) AND STREPTOCOCCAL DESOXYRIBONUCLEASE ON FIBRINOUS, PURULENT, AND SANGUINOUS PLEURAL EXUDATIONS.链球菌纤维蛋白溶酶（链激酶）和链球菌脱氧核糖核酸酶对患者纤维蛋白性、脓性和血性胸腔渗出液的作用
J Clin Invest. 1949 Jan;28(1):173-90. doi: 10.1172/JCI102046.
2
The effect in patients of streptococcal fibrinolysin and streptococcal desoxyribonuclease on fibrinous, purulent, and sanguinous pleural exudations.链球菌纤维蛋白溶酶和链球菌脱氧核糖核酸酶对患者纤维蛋白性、脓性和血性胸腔渗出液的作用。
J Clin Invest. 1949 Jan;28(1):173-90.
3
The action of streptococcal desoxyribonuclease (streptodornase) on purulent exudates.链球菌脱氧核糖核酸酶（链道酶）对脓性渗出物的作用。
Trans N Y Acad Sci. 1952 Jan;14(3):138-40. doi: 10.1111/j.2164-0947.1952.tb01080.x.
4
The inhibition of streptococcal desoxyribonuclease by rabbit and human antisera.兔抗血清和人抗血清对链球菌脱氧核糖核酸酶的抑制作用。
J Exp Med. 1949 Dec;90(6):543-53. doi: 10.1084/jem.90.6.543.
5
THE ACTION OF STREPTOCOCCAL DESOXYRIBOSE NUCLEASE (STREPTODORNASE)IN VITRO AND ON PURULENT PLEURAL EXUDATIONS OF PATIENTS.链球菌脱氧核糖核酸酶（链道酶）的体外作用及对患者脓性胸腔渗出液的作用
J Clin Invest. 1949 Sep;28(5 Pt 2):1094-104. doi: 10.1172/JCI102142.
6
The streptokinase-plasminogen system. II. Its effect on the development of local streptococcal infections in rabbit skin.链激酶-纤溶酶原系统。II. 其对兔皮肤局部链球菌感染发展的影响。
J Infect Dis. 1963 Mar-Apr;112:134-42. doi: 10.1093/infdis/112.2.134.
7
The action of streptococcal desoxyribose nuclease in vitro and on purulent pleural exudations of patients.链球菌脱氧核糖核酸酶在体外的作用以及对患者脓性胸腔渗出液的作用。
J Clin Invest. 1949 Sep;28(5 Pt 2):1094-1104.
8
THE STREPTOKINASE-PLASMINOGEN SYSTEM. III. HISTOPATHOLOGY OF ENHANCED STREPTOCOCCAL VIRULENCE IN RABBIT SKIN DUE TO ACTIVATION OF THIS SYSTEM.链激酶-纤溶酶原系统。III. 该系统激活导致兔皮肤中链球菌毒力增强的组织病理学研究
J Infect Dis. 1963 Sep-Oct;113:77-85. doi: 10.1093/infdis/113.2.77.
9
The streptokinase-plasminogen system. I. Its effect on the pathogenicity of streptococci and other organisms for mice.链激酶-纤溶酶原系统。I. 其对链球菌及其他微生物对小鼠致病性的影响。
J Exp Med. 1959 Aug 1;110(2):245-58. doi: 10.1084/jem.110.2.245.
10
[Enzymatic debridement of wounds. Comparison of 2 commercial preparations].[伤口的酶促清创术。两种商业制剂的比较]
Fortschr Med. 1983 Nov 3;101(41):1883-8.

引用本文的文献

1
Research Priorities for Malignant Pleural Organization with Loculation and Failed Drainage.伴有分隔及引流失败的恶性胸腔积液的研究重点
Cells. 2025 Jul 21;14(14):1118. doi: 10.3390/cells14141118.
2
Intrapleural Fibrinolytic Interventions for Retained Hemothoraces in Rabbits.兔血胸遗留中胸腔内纤维蛋白溶解介入治疗。
Int J Mol Sci. 2024 Aug 12;25(16):8778. doi: 10.3390/ijms25168778.
3
Diagnosis and management of pleural infection.胸膜感染的诊断与管理

本文引用的文献

1
METHODS FOR MEASURING THE ACTIVITY OF COMPONENTS OF THE STREPTOCOCCAL FIBRINOLYTIC SYSTEM, AND STREPTOCOCCAL DESOXYRIBONUCLEASE.测量链球菌纤维蛋白溶解系统各组分活性及链球菌脱氧核糖核酸酶的方法
J Clin Invest. 1949 Jan;28(1):163-72. doi: 10.1172/JCI102045.
2
STUDIES OF STREPTOCOCCAL FIBRINOLYSIS. I. THE DISSIMILARITY OF SERUM PROTEASE AND TRYPSIN AS INDICATED BY THE SEPARATE SPECIFICITIES OF THEIR KINASES, FIBRINOLYSIN AND ENTEROKINASE.链球菌纤维蛋白溶解研究。I. 血清蛋白酶与胰蛋白酶的差异，由其激酶、纤维蛋白溶酶和肠激酶的不同特异性表明
J Clin Invest. 1946 May;25(3):331-6. doi: 10.1172/JCI101713.
3
THE OCCURRENCE OF ANTIFIBRINOLYTIC PROPERTIES IN THE BLOOD OF PATIENTS WITH ACUTE HEMOLYTIC STREPTOCOCCUS INFECTIONS.
Breathe (Sheff). 2023 Dec;19(4):230146. doi: 10.1183/20734735.0146-2023. Epub 2024 Jan 16.
4
The Fibrinolytic System and Its Measurement: History, Current Uses and Future Directions for Diagnosis and Treatment.纤维蛋白溶解系统及其检测：用于诊断和治疗的历史、当前用途和未来方向。
Int J Mol Sci. 2023 Sep 16;24(18):14179. doi: 10.3390/ijms241814179.
5
Tissue plasminogen activator with prolonged dwell time effectively evacuates pleural effusions.具有延长驻留时间的组织型纤溶酶原激活物能有效地排出胸腔积液。
BMC Pulm Med. 2022 Dec 5;22(1):464. doi: 10.1186/s12890-022-02261-y.
6
Fibrinolysis Shutdown and Hypofibrinolysis Are Not Synonymous Terms: The Clinical Significance of Differentiating Low Fibrinolytic States.纤溶抑制和低纤溶不是同义词：区分低纤溶状态的临床意义。
Semin Thromb Hemost. 2023 Jul;49(5):433-443. doi: 10.1055/s-0042-1758057. Epub 2022 Nov 1.
7
From Chest Wall Resection to Medical Management: The Continued Saga of Parapneumonic Effusion Management and Future Directions.从胸壁切除到药物治疗：肺炎旁胸腔积液管理的持续历程及未来方向
Cureus. 2022 Jan 7;14(1):e21017. doi: 10.7759/cureus.21017. eCollection 2022 Jan.
8
Thrombolytic Enzymes of Microbial Origin: A Review.微生物来源的溶栓酶：综述。
Int J Mol Sci. 2021 Sep 28;22(19):10468. doi: 10.3390/ijms221910468.
9
Management of complex pleural disease in the critically ill patient.危重症患者复杂胸膜疾病的管理
J Thorac Dis. 2021 Aug;13(8):5205-5222. doi: 10.21037/jtd-2021-31.
10
Management of Pleural Infection.胸腔感染的管理
Pulm Ther. 2021 Jun;7(1):59-74. doi: 10.1007/s41030-020-00140-7. Epub 2020 Dec 9.
急性溶血性链球菌感染患者血液中抗纤溶特性的出现
J Clin Invest. 1935 Mar;14(2):276-84. doi: 10.1172/JCI100675.
4
FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI. THE DEVELOPMENT OF RESISTANCE TO FIBRINOLYSIS FOLLOWING ACUTE HEMOLYTIC STREPTOCOCCUS INFECTIONS.溶血性链球菌的纤溶活性。急性溶血性链球菌感染后对纤维蛋白溶解抵抗力的发展。
J Clin Invest. 1934 Jan;13(1):47-78. doi: 10.1172/JCI100579.